The following are the reasons that india is emerging as an epicentre for global clinical trials. This movement parallels findings from pharmacovigilance career reports, showing how global hubs attract skilled monitors This growth is attributed to 10 modifications to the drugs and cosmetics act since 2013, aimed at simplifying the process. Clinical trials will be a pivotal part of india’s attempts to scale the global pharmaceutical value chain India's clinical trial industry has surged into the top three globally, driven by regulatory reforms, affordability, vast patient pools, and growing international confidence, positioning. The ongoing reforms in the clinical trial regulatory landscape, the large patient pool, the clinical research technology and talent pools make india an attractive destination for clinical trials.
In light of the challenges faced by the clinical trial industry, the indian government has implemented several reforms aimed at attracting global studies One of the significant changes includes the streamlining of the regulatory process to reduce delays in approvals.
WATCH
